Additional content of the national risk-based control plans and the national randomised surveillance plan
Article 1
Implementing Regulation (EU) 2022/1646 is amended as follows: (1) Article 7 is replaced by the following: ‘Article 7 Additional content of the national risk-based control plans and the national randomised surveillance plan 1. The national risk-based control plans, referred to in Articles 4 and 6, and the national randomised surveillance plan, referred to in Article 5, shall specify the following: (a) the species to be sampled and the place of sampling; (b) the national legislation on the use of pharmacologically active substances and, in particular, their prohibition or their authorisation, distribution, placing on the market and administration, in so far as that legislation is not harmonised by Union legislation; (c) the competent authorities responsible for the implementation of the plans. 2. The national risk-based control plans referred to in Articles 4 and 6 shall, in addition to the information specified in paragraph 1, provide the following: (a) a justification for the selected substances, species, products and matrices included in the plans on the basis of the criteria listed in Annexes II and VI to Delegated Regulation (EU) 2022/1644, including a justification on how the criteria listed in those Annexes were taken into account, even if no changes were made compared to the plans of the previous year; (b) a justification on how cases of non-compliance in the relevant Member State detected in the previous three calendar years were taken into account for optimising the plans. Member States are not required to submit information already provided in the general part of MANCPs in accordance with Article 110(2) of Regulation (EU) 2017/625.’ ; (2) the heading of Article 8 is replaced by the following: ‘ Submission and evaluation of the national risk-based control plans and the national randomised surveillance plan ’; (3) Article 9 is replaced by the following: ‘Article 9 Submission of data by the Member State By 30 June each year, Member States shall transmit to the European Food Safety Authority (“EFSA”) all data from the previous year, including compliant results of screening methods where no confirmatory analyses were performed, gathered under the control plans and the surveillance plan referred to in Article 3. Those data shall also contain the type of follow-up measures taken by the competent authorities with regard to animals or products of animal origin in which non-compliant residues were detected in the previous year. By 31 August each year, Member States shall finalise the data validation, review and final acceptance in the EFSA data repository systems.’; (4) in Annex I, in the ‘additional provisions’, point (b) is replaced by the following: ‘(b) Controls on each combination of sub-groups of Group A substances and commodity groups as listed in Annex II to Delegated Regulation (EU) 2022/1644 shall be performed annually in minimum 5 % of the samples taken in accordance with the table of this Annex for that commodity group. This minimum percentage does not apply to casings, and it does not apply to substance groups A(3), point (b) and A(3), point (f) for all commodity groups.’.